Thousands of cancer patients in Britain have been waiting a long time for the availability of new treatments and personalized vaccines. Thirty hospitals within the scope of the National Health Service (NHS) have been working on this issue for some time. Cancer Vaccine Project attended. In this system, cancer patients are matched with studies that use mRNA technology.

Although there is a common disease called cancer, there is no cancer virus or microbe; this occurs as a result of deterioration of the genetic structure. Although cancer structures generally look similar, they develop based on the individual’s gene structure. mRNA structures It provides a more effective treatment because it is adapted to different genetic structures.

It has been used before

55 years old Elliot PfebveHe became the first person in Britain to be treated with a personalized bowel cancer vaccine. Elliot, who had previously undergone surgery and chemotherapy, was vaccinated at the Queen Elizabeth Hospital in Birmingham. Speaking on this subject, Pfebve said: “If successful, it will be a medical breakthrough. It could help thousands of people and give them hope.” said.

Tests performed after Pfebve’s first treatment showed no cancer in his bloodstream. DNA It turned out he had parts, so Pfebve volunteered for the vaccine. So the goal is to prevent cancer from returning. German pharmaceutical company will use the mRNA vaccine BioNTech has his signature.

Although vaccines normally have preventive properties, cancer vaccines can be used for therapeutic purposes. These vaccines prepare the body to look for cancer, and the body can then eliminate the cancerous patterns that appear.